The study of Soto-Becerra et al is cited by the NIH COVID-19 Treatment Guidelines in forming its recommendation on ivermectin. The Guidelines state:
“Some clinical studies showed no benefits or worsening of disease after ivermectin use…”
Soto-Becerra et al is the only study cited by the NIH showing worsening of outcomes in patients with COVID-19 treated with ivermectin. That study deviated from the prescribed clinical protocol in a multitude of respects. Furthermore, those violations were never reported in the publication.
The clinical protocol is not publicly available, to our knowledge, but an excerpt from the protocol was released in a document, Memorando №1843 from Instituto de Evaluación de Technologias en Salud e Investigación (IETSI), the institute that employed the authors of the study. Other information about the clinical protocol is disclosed in another document, Nota № 38, released from the same organization. An administrator at the IETSI expressed concern about the differences between the study protocol and the publication in Memorando №1843:
“The study protocol shows differences in name and content with the dist...
Note: If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).